Dashboard
Manage Tickers

VRCA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

verrica-pharmaceuticals-gets-european-medicines-agencys-committees-positive-feedback-to-file-marketing-authorization-application-for-ycanth-to-treat-molluscum-contagiosum
Verrica Pharmaceuticals Gets European Medi...
10/20/2025 20:09:30

Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ:VRCA), a dermatology therapeutics company dev...

verrica-pharmaceuticals-to-present-phase-2-data-on-vp-315-for-basal-cell-carcinoma-at-sitc-2025-annual-meeting
Verrica Pharmaceuticals To Present Phase 2...
10/07/2025 20:08:03

Verrica Pharmaceuticals Inc. ("Verrica") (NASDAQ:VRCA), a dermatology therapeutics company developing and selling medic...

verrica-pharmas-development-partner-torii-pharma-receives-approval-from-japanese-mhlw-for-ycanth-for-treatment-of-molluscum-contagiosum
Verrica Pharma's Development Partner, Tori...
09/19/2025 12:12:26

– Approval triggers $10 million cash milestone payment to Verrica –– YCANTH® approval in Japan addresses significant unmet need...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
09/19/2025 12:09:04

verrica-pharmaceuticals-development-partner-torii-pharmaceutical-receives-japan-approval-for-ycanth-in-treatment-of-molluscum-contagiosum-approval-triggers-10m-payment-to-verrica
Verrica Pharmaceuticals Development Partne...
09/19/2025 12:03:34

verrica-pharmaceuticals-q2-adj-eps-025-beats-007-estimate-sales-12702m-beat-4367m-estimate
Verrica Pharmaceuticals Q2 Adj. EPS $0.25 ...
08/12/2025 20:02:39

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate ...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

what-to-expect-from-verrica-pharmaceuticalss-earnings
What to Expect from Verrica Pharmaceutical...
08/11/2025 20:03:43

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
07/25/2025 12:55:12

verrica-pharmaceuticals-to-effect-a-reverse-stock-split-at-a-ratio-of-1-for-10-effective-at-500-pm-eastern-time-on-july-24-8k
Verrica Pharmaceuticals To Effect A Revers...
07/25/2025 09:44:18

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
07/24/2025 23:50:04

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/17/2025 21:06:00

verrica-reports-record-13434-ycanth-applicator-units-dispensed-in-q2-2025-marking-328-sequential-growth
Verrica Reports Record 13,434 YCANTH Appli...
07/09/2025 11:05:14

– Company reports sequential quarterly growth of 32.8% over Q1 2025 with a record 13,434 YCANTH Dispensed applicator units in Q...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
07/07/2025 21:06:29

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/01/2025 12:07:35

verrica-pharmaceuticals-announces-second-amendment-to-its-existing-collaboration-and-licensing-agreement-with-torii-pharmaceutical-to-initiate-a-global-pivotal-phase-3-trial-of-verricas-ycanth-for-common-warts
Verrica Pharmaceuticals Announces Second A...
07/01/2025 11:06:55

Verrica to receive a $8 million milestone payment for initiation of the global study in July 2025, ahead of previous schedule.V...

needham-reiterates-hold-on-verrica-pharmaceuticalsto-hold
Needham Reiterates Hold on Verrica Pharmac...
05/14/2025 16:49:06

Needham analyst Serge Belanger reiterates Verrica Pharmaceuticals (NASDAQ:VRCA) from Hold to Hold.

verrica-pharmaceuticals-q1-adj-eps-008-beats-010-estimate-sales-344m-beat-251m-estimate
Verrica Pharmaceuticals Q1 Adj. EPS $(0.08...
05/13/2025 20:13:13

Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate ...

Core News & Articles
Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

earnings-outlook-for-verrica-pharmaceuticals
Earnings Outlook For Verrica Pharmaceuticals
05/12/2025 20:09:02

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION